Tango reports Phase 1/2 pancreatic cancer data, eyes Phase 3 as it posts Q2 2026 resultsAug 11Quarterly updateTango Therapeutics, Inc.
Erasca updates ERAS-0015 data, plans registration-enabling trials, reports Q2 2026 resultsAug 11Quarterly updateERAS-0015Erasca, Inc.
Sign inSign in